Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited Share · INE044A01036 (XNSE) — real-time quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak

Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Sun Pharmaceutical Industries Limited
No Price
Closing Price XNSE 30.04.2026: 1.810,00 INR
30.04.2026 10:21
Current Prices from Sun Pharmaceutical Industries Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
SUNPHARMA.BO
INR
30.04.2026 10:21
1.808,20 INR
-
XNSE: NSE
NSE
SUNPHARMA.NS
INR
30.04.2026 10:00
1.810,00 INR
-
Share Float & Liquidity
Free Float 44,51 %
Shares Float 1,07 B
Shares Outstanding 2,4 B
Invested Funds

The following funds have invested in Sun Pharmaceutical Industries Limited:

Fund
iShares MSCI India UCITS ETF USD (Acc)
Vol. in million
10.996,34
Percentage (%)
0,94 %
Fund
iShares MSCI EM Islamic UCITS ETF USD (Dist)
Vol. in million
454,51
Percentage (%)
0,42 %
Fund
iShares MSCI EM ex-China UCITS ETF USD (Acc)
Vol. in million
27,47
Percentage (%)
0,16 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Dist)
Vol. in million
316,80
Percentage (%)
0,10 %
Fund
iShares MSCI EM IMI ESG Screened UCITS ETF USD (Acc)
Vol. in million
1.603,76
Percentage (%)
0,10 %
Company Profile for Sun Pharmaceutical Industries Limited Share
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Company Data

Name Sun Pharmaceutical Industries Limited
Company Sun Pharmaceutical Industries Limited
Website https://www.sunpharma.com
Primary Exchange XNSE NSE
ISIN INE044A01036
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Dilip Shantilal Shanghvi
Market Capitalization 4.339 Mrd.
Country India
Currency INR
Employees 43,0 T
Address Sun House, 400063 Mumbai
IPO Date 1996-01-01
Dividends from 'Sun Pharmaceutical Industries Limited'
Ex-Date Dividend per Share
05.02.2026 11,00 INR
07.07.2025 5,50 INR
06.02.2025 10,50 INR
12.07.2024 5,00 INR
09.02.2024 8,50 INR
28.07.2023 4,00 INR
08.02.2023 7,50 INR
19.08.2022 3,00 INR
09.02.2022 7,00 INR
23.08.2021 2,00 INR

Stock Splits

Date Split
29.07.2013 2:1
25.11.2010 5:2
27.05.2004 2:1
13.01.2003 2:1
08.03.2000 3:1
06.03.2000 3:1

Ticker Symbols

Name Symbol
MSE SUNPHARMA.BO
NSE SUNPHARMA.NS
More Shares
Investors who hold Sun Pharmaceutical Industries Limited also have the following shares in their portfolio:
DEKA        MTN IS.S.7869
DEKA MTN IS.S.7869 Bond
INVESTEC BANK PLC IM EVEN 30 6 YR 90% CAP PRO NTS 20/01/22
INVESTEC BANK PLC IM EVEN 30 6 YR 90% CAP PRO NTS 20/01/22 Bond